Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neurogene Inc (NGNE)

Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 548,534
  • Shares Outstanding, K 12,980
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,320 K
  • 60-Month Beta 1.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.12
Trade NGNE with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.02
  • Number of Estimates 5
  • High Estimate -0.89
  • Low Estimate -1.14
  • Prior Year -0.80
  • Growth Rate Est. (year over year) -27.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.15 +43.68%
on 06/26/24
49.05 -11.68%
on 07/15/24
+12.31 (+39.70%)
since 06/21/24
3-Month
28.09 +54.22%
on 04/25/24
49.05 -11.68%
on 07/15/24
+12.71 (+41.52%)
since 04/22/24
52-Week
12.20 +255.08%
on 08/14/23
53.00 -18.26%
on 03/22/24
+29.42 (+211.65%)
since 07/21/23

Business Summary

Neurogene Inc. is a clinical-stage company which bring life-changing genetic medicines to patients and families affected by rare neurological diseases. Neurogene Inc., formerly known as Neoleukin Therapeutics Inc., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 47.52
2nd Resistance Point 46.25
1st Resistance Point 44.79
Last Price 43.32
1st Support Level 42.06
2nd Support Level 40.79
3rd Support Level 39.33

See More

52-Week High 53.00
Last Price 43.32
Fibonacci 61.8% 37.41
Fibonacci 50% 32.60
Fibonacci 38.2% 27.79
52-Week Low 12.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar